Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on July 26, 2005
Secondary metabolites produced from fermentation of actinomycetes are one of the most important sources of pharmaceuticals. Microbia, Inc. announced yesterday that its Precision Engineering business unit has entered into a research collaboration with A*STAR's Bioprocessing Technology Institute (BTI) in Singapore to improve the efficiency of secondary metabolite production from actinomycete bacteria. This will allow BTI scientists to use Microbia's profiling and informatic methods to speed up production of actinomycete metabolites for use in cancer therapeutics.
Download the press release here.
"By combining Microbia's powerful platform for engineering industrial microbes with our strong technology base in, and deep knowledge of, genomics and process development, we aim to create a new paradigm for more efficient and cost-effective production of pharmaceutical compounds from actinomycetes," said Miranda Yap, Executive Director of BTI.
Download the press release here.
Permalink: Microbia Collaborates with A*Star
Tags:
microbial
antibiotics
biotech
microbia
a*star
microbia+collaborates
proteomics+bioinformatics
corpor
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/7961
Mr Wong
Vote for Microbia Collaborates with A*Star:
|
Rating: 6.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







